Dreyer, T. J., Keen, J. A. C., Wells, L. M., Hopkinson, M., Orriss, I. R., Holdsworth, G., . . . Roberts, S. J. Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies. Nature Publishing Group.
Chicago Style (17th ed.) CitationDreyer, Timothy J., Jacob A. C. Keen, Leah M. Wells, Mark Hopkinson, Isabel R. Orriss, Gill Holdsworth, Andrew A. Pitsillides, and Scott J. Roberts. Porcupine Inhibition Is a Promising Pharmacological Treatment for Severe Sclerosteosis Pathologies. Nature Publishing Group.
MLA (9th ed.) CitationDreyer, Timothy J., et al. Porcupine Inhibition Is a Promising Pharmacological Treatment for Severe Sclerosteosis Pathologies. Nature Publishing Group.
Warning: These citations may not always be 100% accurate.